What is DexCare?
Based in Seattle, WA, DexCare operates as a crucial health system capacity management platform-as-a-service (PaaS) provider. The company addresses critical challenges within healthcare delivery by offering solutions designed to streamline operations and enhance patient access. By leveraging technology, DexCare aims to improve the efficiency of healthcare resources, enabling health systems to better manage patient flow, appointment scheduling, and resource allocation. This focus on operational excellence positions DexCare as a key player in the evolving landscape of healthcare technology, particularly in its ability to drive significant improvements in system capacity and patient care coordination.
How much funding has DexCare raised?
DexCare has raised a total of $70M across 2 funding rounds:
Series A
$20M
Series B
$50M
Series A (2021): $20M with participation from Kaiser Permanente Ventures, SpringRock Ventures, Providence Ventures, Define Ventures Management, and Frist Cressey Ventures
Series B (2022): $50M led by SpringRock Ventures, Transformation Capital, Providence Ventures, Mass General Brigham, Define Ventures Management, Kaiser Permanente, and Frist Cressey Ventures
Key Investors in DexCare
Kaiser Permanente Ventures
Kaiser Permanente Ventures is a national leader in strategic venture investing in healthcare, focusing on advancing healthcare innovation. The company partners with entrepreneurs to build promising healthcare solutions that provide clear value for patients, providers, and healthcare delivery systems.
SpringRock Ventures
SpringRock Ventures is an investment firm focused on the convergence of healthcare and information technology, targeting innovative companies in sectors such as SAAS, devices, services, security, genomics, and oral health. They invest in early to late stage, high growth-potential companies.
Providence Ventures
Allumia Ventures, formerly known as Providence Ventures, operates in Seattle, WA and Menlo Park, CA. The company focuses on providing venture capital services. Their intended clients include startups and businesses seeking investment to grow and innovate.
What's next for DexCare?
With substantial backing and a clear focus on health system capacity management, DexCare is poised for accelerated growth and innovation. The recent major strategic investment signals strong confidence from its investors in the company's business model and its potential to scale. This capital infusion will likely fuel further development of its platform, expansion into new markets, and enhancement of its service offerings. DexCare's strategic positioning within the health tech industry, coupled with its ability to secure significant financing, suggests a future focused on solidifying its market leadership and driving further advancements in healthcare operational efficiency.
See full DexCare company page
